Biosimilar Regulatory Guidelines in India and Emerging Markets Webinar

January 15, 2013 8:33 AM

Xtalks presents a live webinar on Thursday, January 24, 2013, 11:00am EST on Biosimilar Regulatory Guidelines in India and Emerging Markets.
Speaker Vijay Tammara, VP Global Regulatory Affairs, Nuron Biotech, AAPS Member, will provide a detailed description of the requirements for registration and post-marketing, as well as a Pharmacovigilance plan.

For companies embarking on a Biosimilar drug development program, the goal is clear, but the road to get there is less so. If you can scientifically demonstrate that a biologic product is highly similar to the approved biologic, you will be able to abbreviate and reduce the burden of preclinical and clinical trials data package as part of submission for market authorization.

The Indian Government has developed and issued guidelines, which apply to similar biologics that contain well-characterized proteins as their active substance, derived through modern biotechnological methods such as the use of recombinant DNA technology.

A live Q&A with the audience will follow the main presentation. For more information, or to register for this event please go to http://xtks.in/xto556.

Would you like to post an event on Biosimilar News?

 

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!